Suppr超能文献

严重双相混合状态的临床亚型。

Clinical subtypes of severe bipolar mixed states.

机构信息

Clinica Psichiatrica, Dipartmento di Medicina Sperimentale, University of Pisa, Pisa, Italy.

出版信息

J Affect Disord. 2013 Dec;151(3):1076-82. doi: 10.1016/j.jad.2013.08.037. Epub 2013 Sep 9.

Abstract

OBJECTIVE

The aim of the present study was to identify different clinical subtypes in severe, treatment resistant bipolar mixed state (MS).

METHOD

The sample comprised 202 Bipolar I patients currently in MS referred for an Electro-convulsive Therapy (ECT) trial and evaluated in the first week of hospitalization and one week after the ECT course. Principal component factor analysis (PCA) followed by Varimax rotation was performed on 21 non-overlapping items selected from Hamilton rating-scale for depression (HAMD) and from Young mania rating-scale (YMRS) at baseline evaluation. Cluster subtypes derived from the factor scores were compared in clinical variables and final HAMD, YMRS, Brief Psychiatric Rating Scale (BPRS) and Clinical Global Impression (CGI) scores.

RESULTS

The principal-component analysis extracted 6 interpretable factors explaining 55.9% of the total variance. Cluster analysis identified four groups, including respectively 63 (31.2%) subjects with Agitated-Irritable Mixed-Depression, 59 (29.2%) with Psychotic Mixed-Mania, 17 (8.5%) with Anxious-Irritable-Psychotic Mixed-Mania, and 63 (31.2%) with Retarded-Psychotic Mixed-Depression. The four clusters were statistically distinct and did not show significant overlap in the main symptomatological presentation. Cluster subtypes reported differences in number of past mood episodes, duration of the current episode, suicide attempts, lifetime comorbidity with panic and eating disorders, baseline and final rating-scale scores and rate of remission after ECT trial.

CONCLUSIONS

Our study indicates that, at least in severe treatment resistant MS, multiple depressive and manic subtypes can be observed with substantial differences in terms of clinical presentation, course, associated comorbidities and treatment response.

摘要

目的

本研究旨在确定重度、治疗抵抗性双相混合状态(MS)中的不同临床亚型。

方法

样本包括 202 名目前处于 MS 且正在接受电休克治疗(ECT)试验的 I 型双相情感障碍患者,在住院的第一周和 ECT 疗程结束后的一周进行评估。在基线评估时,对来自汉密尔顿抑郁评定量表(HAMD)和 Young 躁狂评定量表(YMRS)的 21 个非重叠项目进行主成分因子分析(PCA),然后进行 Varimax 旋转。根据因子得分得出的聚类亚型在临床变量和最终的 HAMD、YMRS、简明精神病评定量表(BPRS)和临床总体印象(CGI)评分方面进行比较。

结果

主成分分析提取了 6 个可解释的因子,解释了总方差的 55.9%。聚类分析确定了 4 个组,分别包括 63 名(31.2%)激越-烦躁混合性抑郁、59 名(29.2%)精神病性混合性躁狂、17 名(8.5%)焦虑-烦躁-精神病性混合性躁狂和 63 名(31.2%)迟滞-精神病性混合性抑郁。这四个聚类在主要症状表现上存在统计学差异,没有明显的重叠。聚类亚型在过去的情绪发作次数、当前发作的持续时间、自杀企图、与惊恐障碍和饮食障碍的终生共病、基线和最终评定量表评分以及 ECT 试验后的缓解率方面存在差异。

结论

我们的研究表明,至少在重度、治疗抵抗性 MS 中,可以观察到多种抑郁和躁狂亚型,它们在临床表现、病程、相关共病和治疗反应方面存在显著差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验